{
    "url_original": "https://www.wsj.com/articles/covid-19-vaccine-maker-blames-problems-on-producing-two-different-shots-11621434060?mod=business_lead_pos4",
    "url": "covid-19-vaccine-maker-blames-problems-on-producing-two-different-shots-11621434060",
    "title": "Emergent Has Made Over 100 Million Doses of J&J Covid-19 Vaccine, CEO Says",
    "sub_head": "Contract manufacturer says FDA, which had found problems at its plant, is evaluating whether the new shots can be released",
    "category_1": "Business",
    "category_2": "Health Care",
    "time": "2021-05-19 15:04:00",
    "body": "Emergent BioSolutions Inc.  has made enough of a key ingredient to yield more than 100 million doses of  Johnson & Johnson ’s  Covid-19 vaccine, and federal health regulators are evaluating whether to release the shots, Emergent’s chief executive said.<br />Emergent CEO Robert Kramer apologized during a congressional hearing Wednesday for the problems at the company’s Baltimore plant that resulted in the contamination earlier this year of a batch of the vaccine.<br />Mr. Kramer said the company, which makes vaccines and drugs under contract, has been taking corrective steps to fix the manufacturing problems at the plant.<br />Emergent has blamed some of the problems on having to produce two Covid-19 vaccines at large scale, which the company said strained the capacity of its equipment. The plant also was making  AstraZeneca  PLC’s Covid-19 vaccine.<br />Emergent described some of the problems and its plan to fix them in a letter to the U.S. Food and Drug Administration, responding to the agency’s finding of various deficiencies during an April inspection."
}